about
Making Sense of the Tangle: Insights into Chromatin Folding and Gene RegulationEnhancers and chromatin structures: regulatory hubs in gene expression and diseases.Tracking the evolution of 3D gene organization demonstrates its connection to phenotypic divergenceControlling gene expression by DNA mechanics: emerging insights and challenges.MrTADFinder: A network modularity based approach to identify topologically associating domains in multiple resolutions.When TADs go bad: chromatin structure and nuclear organisation in human diseaseLooking beyond the genes: the role of non-coding variants in human disease.Predicting chromatin architecture from models of polymer physics.Topologically associated domains: a successful scaffold for the evolution of gene regulation in animals.Activation of the alpha-globin gene expression correlates with dramatic upregulation of nearby non-globin genes and changes in local and large-scale chromatin spatial structure.Hi-C 2.0: An optimized Hi-C procedure for high-resolution genome-wide mapping of chromosome conformation.Cohesins and condensins orchestrate the 4D dynamics of yeast chromosomes during the cell cycle.Gene functioning and storage within a folded genomeA Polymer Physics Investigation of the Architecture of the Murine Orthologue of the 7q11.23 Human Locus.Conserved non-coding elements: developmental gene regulation meets genome organization.The role of epigenomics in personalized medicine.Impact of CAR agonist ligand TCPOBOP on mouse liver chromatin accessibility.Putative bovine topological association domains and CTCF binding motifs can reduce the search space for causative regulatory variants of complex traits.Controlling gene expression by DNA mechanics: emerging insights and challengesA tissue-specific self-interacting chromatin domain forms independently of enhancer-promoter interactionsEffective normalization for copy number variation in Hi-C dataRevealing a human p53 universe
P2860
Q28075462-3A74DA4A-2CC1-4268-AC59-536CC9138CA1Q33613467-2FFC4E5A-3A6B-434A-9DEC-3637DA405491Q33636006-3EE06C63-FDF1-474E-AEA1-60D08C94FDF5Q33639813-5BBA10CC-937C-493A-AF4A-276E64997952Q38696408-21FDD8D5-18CF-4B56-854F-FE64EF4E0FF4Q38837419-867C7BDE-6E15-46C2-8794-E54523B0BA4EQ38880251-F3C7020D-BB87-40FC-83C3-893E387C3FE9Q39030113-6B1A9595-1B05-4402-9430-FFC7E9F4983BQ39157796-C19697A5-1096-4ADE-B7B3-EB1F16ADCDADQ39541242-1B26A26E-C208-4F69-9FD4-AFC252965886Q40463215-7A0B0ADE-01FF-4BA2-8915-5026CA5908F4Q41040321-A0B90177-C2F9-4064-B4B1-1EB81755A725Q41554525-67675530-AF0F-4444-A6D4-B61A8E68DEDAQ42654182-0B6E5D4B-6E3E-4037-B4AE-C86382EE35EEQ47112088-DC12DCD6-7239-4587-892D-7FEA2BBB9CA5Q49584264-2085A4F0-DA87-45D4-AB1A-B298F0FA4422Q53278382-8D909C48-2058-4A5B-BFDA-332A584C5FD6Q55339380-23BD7563-8574-4AE2-985A-2D936FA660EBQ57754359-B5586F8D-E649-4E4F-BE32-558D37735A03Q58124035-E0789533-7B12-48A1-B2CE-33E3CE12E908Q58761827-2853C33E-6142-4778-BDCD-75C5EF2E0B27Q58788860-568A7480-8E38-4B16-AD81-41F35290C797
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
TAD disruption as oncogenic driver.
@en
type
label
TAD disruption as oncogenic driver.
@en
prefLabel
TAD disruption as oncogenic driver.
@en
P2860
P1476
TAD disruption as oncogenic driver.
@en
P2093
Anne-Laure Valton
Job Dekker
P2860
P356
10.1016/J.GDE.2016.03.008
P577
2016-04-22T00:00:00Z